Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3331939 | Hematology/Oncology Clinics of North America | 2009 | 17 Pages |
Abstract
Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized clinically by the triad of abnormal nails, reticular skin pigmentation, and oral leukoplakia, and is associated with high risk of developing aplastic anemia, myelodysplastic syndrome, leukemia, and solid tumors. Patients have very short germline telomeres, and approximately half have mutations in one of six genes encoding proteins that maintain telomere function. Accurate diagnosis of DC is critical to ensure proper clinical management, because patients who have DC and bone marrow failure do not respond to immunosuppressive therapy and may have increased morbidity and mortality associated with hematopoietic stem cell transplantation.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Sharon A. MD, FAAP, Blanche P. MD, MPH, FAAP,